Source: CureToday articles
Richard Winneker gathers input from patients and researchers to shape MPN research, aiming to fund strategic projects for this population.
Recent Content
- AACR 2025: High Response Rates With Dostarlimab Suggest New Standard for dMMR Treatment
- How Mammogram Reminders Can Be More Thoughtful Following Breast Cancer
- AACR 2025: ctDNA Testing Identifies Recurrence Risk Within Weeks of Surgery in Colorectal Cancer
- AACR 2025: ctDNA-Guided Adjuvant PD-1 Blockade Shows Promise for Patients With Resected dMMR Solid Tumors
- TAR-200 Achieves High DFS and Bladder Preservation Rates in Bladder Cancer Subgroups
- Fellowship Focus: Elevating Pediatric Medication Safety Through Data, AI, and Collaboration
- Zongertinib Elicits Responses in HER2-Mutant NSCLC
- Moderate Alcohol Consumption Could Help Prevent Rheumatoid Arthritis
- Weighing the Benefits and Risks of Statin Therapy
- Important Treatment Considerations With LDL-C– Lowering Therapies